What is the prevalence of Cherubism?

Cherubism is an ultra-rare genetic condition with an estimated prevalence of less than 1 in 1,000,000 worldwide, though exact figures are difficult to determine due to significant underdiagnosis. While Cherubism is typically identified in early childhood, the condition often stabilizes or regresses after puberty, meaning true global prevalence remains speculative.

How common is Cherubism and is it considered rare?

Cherubism is classified as an ultra-rare disease. Because the jaw-related symptoms of Cherubism can sometimes be mild or misidentified as other fibrous bone lesions, many cases likely go unreported or undiagnosed. Currently, the DiseaseMaps.org community includes 2 members living with this condition, highlighting the rarity and the value of global patient networking for such isolated diagnoses.

What is the age of onset and gender distribution for Cherubism?

Symptoms of Cherubism typically emerge in early childhood, usually between the ages of 2 and 7 years. The condition affects both males and females, with no clear evidence of a significant gender bias in clinical literature. Data regarding geographic or ethnic distribution is limited, but Cherubism has been reported in diverse populations globally.

Why is accurate epidemiological data for Cherubism challenging to collect?

Several factors contribute to the difficulty in quantifying Cherubism cases:

• Variable Expressivity: Some individuals carry the causative SH3BP2 gene mutation but exhibit very mild or asymptomatic jaw involvement.


• Spontaneous Regression: As patients reach adulthood, the characteristic fibro-osseous lesions often fill with normal bone, leading to a "hidden" prevalence in the adult population.


• Diagnostic Confusion: Cherubism is frequently confused with other giant cell lesions of the jaw, leading to misclassification in medical registries.

Next steps

• Consult with a craniofacial surgeon or a pediatric geneticist to confirm a diagnosis through clinical evaluation and genetic testing.


• Monitor bone health through regular dental and radiographic imaging as recommended by your specialist.


• Join the DiseaseMaps.org community to connect with other families and share experiences regarding the management of Cherubism.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Rare Disease Database (ORPHA:155)


• NIH Genetic and Rare Diseases Information Center (GARD)


• OMIM (Online Mendelian Inheritance in Man): #118400


• PubMed: Clinical studies on SH3BP2 mutation-related fibro-osseous lesions